Trends in European Disposable E-cigarette Market's New Flavors

Apr.27.2023
Trends in European Disposable E-cigarette Market's New Flavors
2FIRSTS analyzes European e-cigarette market trends through multiple perspectives, revealing new flavor trends and growth in disposable e-cigarettes.

Recently, 2FIRSTS conducted a comprehensive analysis of the European e-cigarette market, focusing on dimensions such as flavor, company, brand, e-liquid, and appearance. This analysis was based on official information from important logistics centers in Europe. By utilizing multiple perspectives, 2FIRSTS was able to gain insight into the future trends of the European e-cigarette market.


Official data released shows that in March, there were 319 new electronic cigarette products introduced in Europe. Disposable e-cigarettes accounted for over 85% of these new products, while pod-based e-liquids and cartridge-based e-liquid kits made up 9.6% and 7.2%, respectively.


2FIRSTS has conducted an in-depth analysis of the European disposable e-cigarette market's new flavor trends from a flavor standpoint, based on this "incremental data." The data shows that the most prominent growth occurred in grape ice, watermelon ice, strawberry ice, and mango peach flavors. Mixed fruit flavors also saw an increase, including strawberry banana, strawberry, blueberry, and cherry blends, as well as kiwi passion fruit guava. Mixed berries had the largest increase, growing 10.7% year-over-year.


It is expected that by October 2023, the aforementioned flavors will become the new flavors with the highest increase in market volume in the European Bai Guan market.


Image: Distribution of mixed flavors of new electronic cigarette products in April | Data source: European Health Department whitelist, 2FIRSTS Note: The above chart only counts the number of times various flavor keywords appear simultaneously. If it is a mixed flavor of three flavors, it will be counted once in each of the two flavors.


Furthermore, there has been a significant increase in flavors such as pineapple, banana, guava, peach, mango, and grape, all with growth rates exceeding 8%. (Note: This increase refers to all flavors containing the respective fruit, including mixed fruit flavors.)


Incremental Contribution Ratio | Image source: 2FIRSTS exclusive compilation. The chart is derived from the free website http://www.flaticon.com.


2FIRSTS will continue to report on research and analysis of the European e-cigarette market. Stay tuned for updates.


The data and images in this article were compiled by 2FIRSTS based on the e-cigarette whitelist published by Belgium. Belgium is an important logistics hub in Europe, with Brussels Airport being a key port for Chinese e-cigarettes to set sail. Additionally, Belgium has established a free trade zone called Benelux with the Netherlands and Luxembourg, allowing for free flow of goods within the trade zone. Belgium requires all imported and manufactured products to be registered and recorded on their "whitelist" six months before being placed on the market. This whitelist is published by the Federal Public Service of Health, Environment and Food Chain Safety in Belgium (FPS Public Health).


Further reading:


According to a market research by 2FIRSTS, narrowing of electronic cigarette flavors is an inevitable trend as the market moves towards further segmentation.


2FIRSTS Market Research: Only Accepting White Labels and Forced Transformation - How is the Russian E-Cigarette Market Doing Under Strong Regulatory Signals?


What impact has the "e-liquid exceeding standards" incident had on the electronic cigarette distributors in Manchester, UK?


2FIRSTS recently interviewed the electronic cigarette brand Fume, which claims to be the first in Florida. The company is currently developing a new hybrid flavor.


A survey conducted by 2FIRSTS on the appearance of electronic cigarettes in Europe found that black, blue, and red are the most popular colors, while green and pink are experiencing the fastest growth.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
JPMorgan resumed equity research coverage of British American Tobacco (BAT), Philip Morris International (PMI) and Imperial Brands in November 2026, assigning BAT an Overweight rating and the other two companies Neutral ratings. The bank forecasts like-for-like sales growth of 3.9% for BAT and 6.2% for PMI in 2027, but estimates the two companies will trade at approximately 11 times and 21 times 2027 earnings, respectively. JPMorgan cited BAT's improving position in US nicotine pouches and vaping products as a driver of its investment outlook. BAT reported a 220% constant-currency increase in US modern oral nicotine revenue in the first half of 2026, while PMI's ZYN US shipments returned to growth in the third quarter. Imperial expects NGPs to represent 4% to 5% of sales and has expanded its oral portfolio through acquisitions.
Capital Markets
Nov.12
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14
Japan Survey Finds 49.5% Would Cut Tobacco Use if Prices Rise, 64.6% Show Interest in Nicotine-Free Alternatives
Japan Survey Finds 49.5% Would Cut Tobacco Use if Prices Rise, 64.6% Show Interest in Nicotine-Free Alternatives
A September online survey commissioned by Japanese smoking-accessories company Lightec found that 49.5% of respondents would consider reducing tobacco use if prices rose further, while 25.1% would consider switching to cheaper brands and 14.5% would consider using or combining alternatives such as vapes and nicotine-free herbal sticks. Another 64.6% expressed some level of interest in such alternatives. The survey covered 1,088 respondents aged 20 to 70 and was conducted by a company that sells NICOLESS nicotine-free vaping and herbal-stick products, meaning its findings should not be treated as representative of Japan's smoking population.
DATA
Oct.12
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-listed consumer goods group Supreme plc says it continues to expect FY27 trading to meet market expectations as the Vaping Products Duty takes effect on October 1, while maintaining a comparatively positive view of the new tax and compliance regime. Supreme has said the framework could increase compliance complexity for smaller operators and contribute to market consolidation, while its manufacturing, compliance and distribution scale may allow it to gain share. Its 88Vape brand will retain its value positioning.
Sep.18
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
During its coverage of Altria's booth at NACS Show 2026, 2Firsts documented product displays that prompted questions about U.S. tobacco advertising warning requirements. Following public comments from a former FDA official, 2Firsts sought responses from Altria and independently consulted U.S. regulatory lawyer Azim Chowdhury. Altria maintained that its B2B communications complied with applicable laws, while Chowdhury explained that federal warning rules provide no general trade-show exemption for e-cigarettes and nicotine pouches. The special report examines the broader regulatory implications.
Nov.04
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives